MR
Maury Raycroft Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $43 |
14%
upside
| 1 | +20% |
0
%
| 3 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $81 |
7%
downside
| 1 | +47% |
0
%
| 2 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $63 |
161%
upside
| 1 | +11% |
0
%
| 30 Dec ‘25 3 months ago |
|
|
|
Hold
Downgraded
| $0.5000 |
72%
upside
| 1 | -41% |
–
| 30 Dec ‘25 3 months ago |
|
|
|
Buy
Maintained
| $134 |
11%
upside
| 1 | +19% |
0
%
| 2 Dec ‘25 4 months ago |
|
|
|
Buy
Upgraded
| $21 |
31%
upside
| 1 | +3.1% |
0
%
| 7 Nov ‘25 5 months ago |
|
|
|
Hold
Downgraded
| $1.60 |
30%
upside
| 1 | – |
–
| 31 Oct ‘25 5 months ago |
|
|
|
Buy
Maintained
| $549 |
80%
upside
| 2 | +5.5% |
0
%
| 30 Oct ‘25 5 months ago |
|
|
|
Hold
Downgraded
| $7 |
5%
downside
| 1 | – |
–
| 17 Oct ‘25 6 months ago |
|
|
|
Buy
Initiated
| $15 |
67%
downside
| 1 | +149% |
0
%
| 22 Sep ‘25 7 months ago |
|
|
|
Hold
Initiated
| $3.50 |
103%
upside
| 1 | – |
–
| 24 Jun ‘25 10 months ago |
|